BT Wealth Management’s Aethlon Medical AEMD Stock Holding History

BT Wealth Management’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1	Closed	-$11K	–	58
2018 Q4	$11K	Buy	+1	New	+$14.5K	﹤0.01%	104

Other funds holding AEMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CFN

Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CWAG

Compton Wealth Advisory Group Virginia Beach, Virginia $495M AUM 23.41% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BT Wealth Management's AEMD Position: Q1 2019 in Review

BT Wealth Management sold out of Aethlon Medical (AEMD) in Q1 2019, closing a stake of 1 share — an estimated $11K sold.

BT Wealth Management first reported a position in AEMD in Q4 2018 and held it in 1 quarter. The position peaked at $11K in Q4 2018. 12 funds tracked by Wall St. Rank hold AEMD as of Q1 2019.

BT Wealth Management reported no remaining Aethlon Medical position as of Q1 2019 after selling out during the quarter.
BT Wealth Management sold 1 Aethlon Medical share in Q1 2019, an estimated $11K.
BT Wealth Management first reported a position in Aethlon Medical in Q4 2018 and held it in 1 quarter.
BT Wealth Management's Aethlon Medical position peaked at $11K in Q4 2018.
12 funds tracked by Wall St. Rank held Aethlon Medical as of Q1 2019.

Based on BT Wealth Management's 13F filing for Q1 2019, filed 15 Apr 2019.